SKM-1 Cells
690,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The SKM-1 cell line is a human leukemia model established from the peripheral blood of a patient with acute monoblastic leukemia that developed from myelodysplastic syndrome (MDS). These cells exhibit immature morphological features, such as a high nucleus-to-cytoplasm ratio and fine azurophilic granules, making them an excellent model for studying the molecular and cellular mechanisms of leukemia, particularly the transition from MDS to acute myeloid leukemia (AML). Genetic analysis of SKM-1 has revealed important chromosomal abnormalities, including del(9)(q13;q22) and der(17)t(17:?)(p13:?); the latter alteration involves the p53 gene, which is overexpressed and harbors mutations in this cell line. These findings highlight the role of p53 in clonal evolution and progression of myeloid malignancies. SKM-1 cells are also characterized by their expression of myelomonocytic markers, including CD4, CD13, and CD33, as well as their positivity for butyrate esterase activity, which aligns with their monoblastic lineage. This cell line is widely used in research on leukemogenesis, drug resistance, and the molecular pathways underlying leukemia. For instance, SKM-1 provides a platform for exploring the impacts of p53 dysfunction and other genetic lesions on cell proliferation and therapeutic response. It also serves as a model for investigating novel therapeutic strategies for myelodysplastic syndromes and secondary AML. |
|---|---|
| Organisme | Human |
| Tissu | Peripheral blood |
| Maladie | acute myleoid leukemia |
| Synonymes | SKM1 |
Caractéristiques
| Âge | 76 years |
|---|---|
| Genre | Male |
| Origine ethnique | Japanese |
| Morphologie | Round cells |
| Propriétés de croissance | Suspension |
Données réglementaires
| Référence | SKM-1 (Cytion catalog number 305627) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_0098 |
Données biomoléculaires
| Expression de l'antigène | CD3 -, CD4 (+), CD13 +, CD14 -, CD15 +, CD19 -, CD33 +, HLA-DR +; |
|---|---|
| Virus | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
| Profil mutationnel | Mutation: ASXL1, Simple, p.Tyr591Ter (c.1773C>A), Homozygous; Mutation: BCORL1, Simple, c.4619-1G>A, Homozygous, Splice acceptor Mutation; Mutation: EZH2, Simple, p.Tyr646Cys (c.1937A>G), Heterozygous; Mutation: KRAS, Simple, p.Lys117Asn (c.351A>C), Homozygous; Mutation: TP53, Simple, p.Arg248Gln (c.743G>A), Homozygous |
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 15% FBS |
| Réactif de dissociation | None |
| Temps de doublement | 48 hours |
| Densité de semis | 0.3 to 1 x 106 cells/ml |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305627-060226 | Certificat d'analyse | 05. Mar. 2026 | 305627 |
-
Related products
Related products
SK-BR-3 CellsOrganisme Human Tissu Breast, mammary gland Maladie Invasive ductal carcinoma 545,10 CAD$*